OPTIMAL PULSE TECHNOLOGY (OPT™) TREATMENT: OPTILIGHT

OptiLight is the first and only IPL FDA approved for management of dry eye disease due to MGD. It is a Step 2 DED treatment, and it is a non-invasive 30 minutes procedure performed with topical anesthetic drops. It uses gentle pulses of light to help break the buildup of oil or other debris blocking the meibomian glands that produce oil for tears.

The lids are then gently massaged to improve the flow of meibum (oil) through the glands, followed by the expression of the melted meibum. OptiLight procedure improves the function of meibomian glands and protects them long term.

For contact lens wearers, each OptiLight procedure often improves wearing time by at least four additional hours. For many of our patients, they report improvement in longer computer work hours and more stable vision. For women patients who wear eye makeup, they report less makeup smearing and watery eyes.

For patients with more severe symptoms, OptiLight can be done quarterly. The procedure is often combined with Microblepharoexfoliation (MBE) Treatment for patients presenting with multiple ocular surface disease (OSD) conditions, including the dry eye disease (DED).